Publications 17 Jul 2024 The Science Explained: Good news for people living with PKDL in Eastern Africa
Press releases 17 Jul 2024 Clinical trial in Eastern Africa finds a shorter, safer, and more effective treatment for PKDL, a stigmatizing skin disease
Scientific articles 2 Jul 2024 Design, conduct, analysis, and reporting of therapeutic efficacy studies in visceral leishmaniasis: A systematic review of published reports, 2000–2021 American Journal of Tropical Medicine and Hygiene
In the media 26 Jun 2024 Framework to help curb visceral leishmaniasis in East Africa Health Policy Watch
In the media 25 Jun 2024 Consider This: Dengue vaccine (part 3) — Pandemic lessons: Prevent vaccine inequity Astro Awani
Press releases 24 Jun 2024 Paediatric malaria treatment developed in Brazil by not-for-profit organizations distributed to Indigenous children in the Amazon region
In the media 22 Jun 2024 What role does capacity development play in transforming health research? Health Policy Watch
Press releases 12 Jun 2024 New framework for visceral leishmaniasis elimination launched for Eastern Africa
Viewpoints 27 Jun 2014 Conducting clinical trials for sleeping sickness in remote areas of the Democratic Republic of the Congo – Overcoming Operational Challenges and Reaping Health System Benefits
Viewpoints 22 May 2014 Modern drug discovery and the fight against NTDs: How can the PDP model enhance and accelerate the R&D process?
Viewpoints 3 Apr 2014 Global Alliance for the Treatment of Chagas Disease: Thinking About the Patients
Viewpoints 12 Nov 2013 WHO R&D ‘Demonstration Projects’: A Member State-driven step towards a sustainable global framework for neglected disease R&D
Viewpoints 11 Sep 2013 The Role of Neglected Disease-Endemic, Emerging-Economy Countries in Neglected Disease R&D: Latin America on the Rise
Viewpoints 13 May 2013 Connect to Fight Neglect: A Decade of Medical Innovations for Neglected Patients
Viewpoints 3 Oct 2012 Regulatory Harmonization in Developing Countries Needed to Speed up Neglected Patients’ Access to New Drugs